跳至主要内容
临床试验/NCT01422291
NCT01422291已完成4 期

Pamukkale University Medical School,Dept. of Emergency Medicine

Pamukkale University0 个研究点目标入组 120 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
120
主要终点
Reduction in visual analogue scale

研究概览

简要总结

This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol, dexketoprofen and morphine for the treatment of low back pain.

详细描述

Study Design and Setting:

This is a single-center, prospective, randomized, double-blind, clinical trial performed in an ED of a tertiary care hospital with annual census of approximately 37.000 visits. The local ethics committee approved the study.

Interventions:

We conducted a randomized, controlled clinical trial comparing single intravenous doses of paracetamol (1 g), dexketoprofen (50 mg) and morphine (0.1 mg/kg) for patients presenting to the emergency department (ED) with suspected low back pain. Subjects with inadequate pain relief at 30 minutes received rescue fentanyl (0.75 microg/kg). We compared changes in pain intensity 30 minutes after treatment.

Methods of Measurements:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
16 Years 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (aged 16 to 55 years) with acute low back pain were eligible for inclusion in the study- -

排除标准

  • Exclusion criteria included known allergy or contraindication to morphine, paracetamol,dexketoprofen or any opioid analgesic
  • Hemodynamic instability
  • Fever (temperature >38°C [100.4°F])
  • Evidence of peritoneal inflammation
  • Documented or suspected pregnancy
  • Known or suspected aortic dissection or aneurysm, lombar disc hernia
  • Use of any analgesic within 6 hours of ED presentation
  • Previous study enrollment.
  • Patients with known renal, pulmonary, cardiac, or hepatic failure, as well as those with renal transplantation, were also excluded.

研究组 & 干预措施

morphine

Active Comparator

干预措施: Paracetamole (Drug)

Paracetamole, dexketoprofen

Experimental

Paracetamole, dexketoprofen

干预措施: paracetamol (Drug)

Paracetamole, dexketoprofen

Experimental

Paracetamole, dexketoprofen

干预措施: morphine (Drug)

Paracetamole, dexketoprofen

Experimental

Paracetamole, dexketoprofen

干预措施: Dexketoprofen (Drug)

结局指标

主要结局

Reduction in visual analogue scale

时间窗: 15 minutes interval

The pain of the study subjects was measured after 15th and 30th minutes later after the study drug administered

次要结局

  • Adverse events.(30 minutes after)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mustafa Serinken

Pamukkale University

Pamukkale University

相似试验